Compare
Kraig Biocraft Laboratories, Inc. vs PureCycle Technologies, Inc. vs Rogers Corp vs AdvanSix Inc.
| Latest fiscal year | Kraig Biocraft Laboratories, Inc. KBLB | PureCycle Technologies, Inc. PCT | Rogers Corp ROG | AdvanSix Inc. ASIX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $8.36M | $810.80M | $1.52B |
| Revenue growth (YoY) | n/a | n/a | -2.3% | +0.3% |
| Gross margin | n/a | n/a | 31.7% | 10.8% (computed) |
| Operating margin | n/a | n/m | -5.6% | n/a |
| Net margin | n/a | n/m | -7.6% | 3.2% |
| Net income | -$3.62M | -$182.56M | -$61.80M | $49.29M |
| EPS (Diluted) | $0.00 | -$1.21 | -$3.40 | $1.80 |
| Operating cash flow | -$1.79M | -$142.74M | $101.20M | $122.86M |
| Free cash flow | -$1.79M | -$183.59M | $71.10M | $6.42M |
| Cash & equivalents | $1.79M | $156.69M | $197.00M | $19.77M |
| Total assets | $2.57M | $922.67M | $1.43B | $1.71B |
| Total liabilities | $10.56M | $572.08M | n/a | $890.93M |
| Shareholders' equity | -$8.00M | $45.89M | $1.20B | $815.22M |
| Return on year-end equity | n/a | -397.9% | -5.2% | 6.0% |
| Shares outstanding | n/a | 180.28M | 17.80M | 26.86M |
Revenue, most recent five fiscal years
| Fiscal year | Kraig Biocraft Laboratories, Inc. | PureCycle Technologies, Inc. | Rogers Corp | AdvanSix Inc. |
|---|---|---|---|---|
| Latest | $401.6K Ended 2018-12-31 | $8.36M Ended 2025-12-31 | $810.80M Ended 2025-12-31 | $1.52B Ended 2025-12-31 |
| 1 year earlier | $97.3K Ended 2017-12-31 | $0 Ended 2024-12-31 | $830.10M Ended 2024-12-31 | $1.52B Ended 2024-12-31 |
| 2 years earlier | $31.9K Ended 2016-12-31 | $0 Ended 2023-12-31 | $908.40M Ended 2023-12-31 | $1.53B Ended 2023-12-31 |
| 3 years earlier | $0 Ended 2015-12-31 | n/a | $971.20M Ended 2022-12-31 | $1.95B Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2014-12-31 | n/a | $932.90M Ended 2021-12-31 | $1.68B Ended 2021-12-31 |